1.Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
Sung Hwan KIM ; Sung Cheol YUN ; Jin Joo PARK ; Sang Eun LEE ; Eun Seok JEON ; Jae Joong KIM ; Myeong Chan CHO ; Shung Chull CHAE ; Seok Min KANG ; Dong Ju CHOI ; Byung Su YOO ; Kye Hun KIM ; Byung Hee OH ; Sang Hong BAEK ;
Korean Circulation Journal 2019;49(3):238-248
BACKGROUND AND OBJECTIVES: Beta-blockers are indicated in patients with heart failure (HF) with reduced ejection fraction. However, their efficacy in patients with HF with preserved ejection fraction (HFpEF) is uncertain. We investigated the hypothesis that beta-blockers are associated with reduced adverse events in patients with HFpEF. METHODS: The Korea Acute Heart Failure (KorAHF) is a prospective observational multicentre cohort study. The 5,625 patients hospitalized for acute HF syndrome in 10 tertiary university hospitals across the country have been consecutively enrolled between March 2011 and February 2014. Of these patients, 2,152 patients with HFpEF (ejection fraction ≥40%) were investigated. The primary outcome was all-cause mortality according to beta-blocker use. RESULTS: During a median follow-up duration of 807 days, 702 patients died. In Cox proportional hazards model beta-blocker use was associated with a 14% reduced all-cause death (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.75–0.98), but not with reduce rehospitalization (HR, 1.03; 95% CI, 0.85–1.27). In the propensity-score matched population, beta-blockers were also associated with reduced all-cause death (HR, 0.80; 95% CI, 0.69–0.94) but not with reduced rehospitalization (HR, 1.08; 95% CI, 0.87–1.33). CONCLUSIONS: In Korean patients with HFpEF, use of beta-blockers is associated with reduced all-cause death but not with reduced rehospitalization.
Cohort Studies
;
Diastole
;
Follow-Up Studies
;
Heart Failure
;
Heart
;
Hospitals, University
;
Humans
;
Korea
;
Mortality
;
Proportional Hazards Models
;
Prospective Studies
2.Urogonimus turdi (Digenea: Leucochloridiidae) from the White’s Thrush, Zoothera aurea, in the Republic of Korea
Hyeon Cheol KIM ; Eui Ju HONG ; Si Yun RYU ; Jinho PARK ; Do Hyeon YU ; Joon Seok CHAE ; Kyoung Seong CHOI ; Cheolho SIM ; Bae Keun PARK
The Korean Journal of Parasitology 2019;57(5):461-467
Avian trematodes, Urogonimus turdi (Digenea: Leucochloridiidae), were collected from the intestine of wild birds, Zoothera aurea, 2013–2017 in the Daejeon Metropolitan City, Korea. The body was ellipsoidal, attenuated and/or round ends, 1,987–2,120 long and 819–831 μm wide. The oral sucker was subterminal, rounded anteriorly, and 308–425×351–432 μm in size; the prepharynx and esophagus were almost lacking; pharynx was well-developed, 142–179×78–170 μm in size; intestine narrow, bifurcating just after pharynx, ascending to the oral sucker before looping posteriorly and terminating near the posterior end; ventral sucker larger, in almost median, 536–673×447–605 μm and approximately 1.5 times larger than oral sucker. A phylogenetic tree constructed with 18S ribosomal RNA showed inter- and intraspecific relationships. Based on these morphological and molecular findings, we report here a U. turdi from White’s thrushes in Korea.
Birds
;
Candidiasis, Oral
;
Esophagus
;
Intestines
;
Korea
;
Pharynx
;
Republic of Korea
;
RNA, Ribosomal, 18S
;
Songbirds
;
Trees
3.Sonographic and Clinical Characteristics of Uterine Sarcoma Initially Misdiagnosed as Uterine Fibroid in Women in the Late Reproductive Age
Ju Hee KIM ; Hyun Jin KIM ; Sung Hoon KIM ; Sun Ah SHIN ; So Yun PARK ; Do Young KIM ; Sa Ra LEE ; Hee Dong CHAE ; Byung Moon KANG
Journal of Menopausal Medicine 2019;25(3):164-171
OBJECTIVES: Uterine sarcoma is a rare malignant tumor, which is usually diagnosed in postmenopausal women. These sarcomas are occasionally misdiagnosed as uterine fibroids, thereby leading to delayed diagnosis in the advanced stages. We analyzed the sonographic and clinical characteristics of unexpected uterine sarcomas detected after surgery in women in the late reproductive age.METHODS: The medical records of 61 patients preoperatively diagnosed with uterine leiomyomas through sonography but confirmed as uterine sarcomas after surgery from January 2005 to December 2018 at Asan Medical Center were retrospectively analyzed. We evaluated the clinical symptoms, sonographic findings, and Doppler indexes, and investigated whether there were any significant characteristics that could clearly differentiate uterine sarcoma from fibroids.RESULTS: The most common clinical finding was increased mass size (15 patients, 24.6%), while 9 patients (14.8%) showed no symptoms. Ultrasonography showed that the maximum diameter of most fibroids was > 5 cm (49 patients, 80.3%), and the average diameter was 75.6 ± 36.3 mm. All the patients showed heterogeneous echogenicity in sonographic imaging. Secondary degeneration of the myomas was reported in 36 patients (59%), and approximately 90% (32/36, 88.9%) showed cystic changes. Of the 40 patients who underwent the evaluation of vascularity, 35 showed increased vascularity of the mass.CONCLUSIONS: In this study, sarcomas misdiagnosed as leiomyomas were usually > 5 cm, and ultrasonography showed heterogeneous echogenicity and irregular cystic degeneration. No definite clinical symptoms were helpful; a thorough evaluation is necessary to rule out uterine sarcomas in women having uterine mass with these characteristics.
Chungcheongnam-do
;
Delayed Diagnosis
;
Diagnostic Errors
;
Female
;
Humans
;
Leiomyoma
;
Medical Records
;
Myoma
;
Retrospective Studies
;
Sarcoma
;
Ultrasonography
4.Hypoxia-dependent mitochondrial fission regulates endothelial progenitor cell migration, invasion, and tube formation.
Da Yeon KIM ; Seok Yun JUNG ; Yeon Ju KIM ; Songhwa KANG ; Ji Hye PARK ; Seung Taek JI ; Woong Bi JANG ; Shreekrishna LAMICHANE ; Babita Dahal LAMICHANE ; Young Chan CHAE ; Dongjun LEE ; Joo Seop CHUNG ; Sang Mo KWON
The Korean Journal of Physiology and Pharmacology 2018;22(2):203-213
Tumor undergo uncontrolled, excessive proliferation leads to hypoxic microenvironment. To fulfill their demand for nutrient, and oxygen, tumor angiogenesis is required. Endothelial progenitor cells (EPCs) have been known to the main source of angiogenesis because of their potential to differentiation into endothelial cells. Therefore, understanding the mechanism of EPC-mediated angiogenesis in hypoxia is critical for development of cancer therapy. Recently, mitochondrial dynamics has emerged as a critical mechanism for cellular function and differentiation under hypoxic conditions. However, the role of mitochondrial dynamics in hypoxia-induced angiogenesis remains to be elucidated. In this study, we demonstrated that hypoxia-induced mitochondrial fission accelerates EPCs bioactivities. We first investigated the effect of hypoxia on EPC-mediated angiogenesis. Cell migration, invasion, and tube formation was significantly increased under hypoxic conditions; expression of EPC surface markers was unchanged. And mitochondrial fission was induced by hypoxia time-dependent manner. We found that hypoxia-induced mitochondrial fission was triggered by dynamin-related protein Drp1, specifically, phosphorylated DRP1 at Ser637, a suppression marker for mitochondrial fission, was impaired in hypoxia time-dependent manner. To confirm the role of DRP1 in EPC-mediated angiogenesis, we analyzed cell bioactivities using Mdivi-1, a selective DRP1 inhibitor, and DRP1 siRNA. DRP1 silencing or Mdivi-1 treatment dramatically reduced cell migration, invasion, and tube formation in EPCs, but the expression of EPC surface markers was unchanged. In conclusion, we uncovered a novel role of mitochondrial fission in hypoxia-induced angiogenesis. Therefore, we suggest that specific modulation of DRP1-mediated mitochondrial dynamics may be a potential therapeutic strategy in EPC-mediated tumor angiogenesis.
Anoxia
;
Cell Movement
;
Endothelial Cells
;
Endothelial Progenitor Cells*
;
Mitochondrial Dynamics*
;
Oxygen
;
RNA, Small Interfering
5.Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial
Doo Sun SIM ; Myung Ho JEONG ; Young Joon HONG ; Ju Han KIM ; Youngkeun AHN ; Keun Ho PARK ; Sun Ho HWANG ; Dong Goo KANG ; Seung Uk LEE ; Joon Woo KIM ; Jong Pil PARK ; Jay Young RHEW ; Sang Rok LEE ; Jei Keon CHAE ; Kyeong Ho YUN ; Seok Kyu OH ; Won You KANG ; Su Hyun KIM ; Jang Hyun CHO
Chonnam Medical Journal 2018;54(1):55-62
The Endeavor Resolute® (ER) is a zotarolimus-eluting stent (ZES) with a biocompatible BioLinx polymer. This study prospectively compared the clinical outcomes of 2 versions of ZES, ER and Endeavor Sprint® (ES), in patients with multivessel disease. A total of 488 patients who underwent multivessel percutaneous coronary intervention (PCI) were divided into 2 groups the ER group (n=288) and the ES group (n=200). The primary endpoint was a composite of major adverse cardiac events (MACE) consisting of death, myocardial infarction, and target vessel revascularization after 12 months. In all patients, the prevalence of diabetes was higher in the ER group (42.7% vs. 31.0%, p=0.009). The rate of post-PCI Thrombolysis in Myocardial Infarction flow grade 3 was higher in the ER group (100.0% vs. 98.0%, p=0.028). There were no between-group differences in the in-hospital, 1-month and 12-month clinical outcomes. In the propensity score matched cohort (n=200 in each group), no differences were observed in the baseline and procedural characteristics. There were no statistical differences in the rates of in-hospital, 1-month and 12-month events (12-month MACE in the ER and ES groups: 6.0% vs. 3.5%, p=0.240, respectively). The safety and efficacy of both versions of ZES were comparable in patients with multivessel disease during a 12-month clinical follow-up.
Cohort Studies
;
Coronary Artery Disease
;
Drug-Eluting Stents
;
Follow-Up Studies
;
Heart
;
Humans
;
Multicenter Studies as Topic
;
Myocardial Infarction
;
Percutaneous Coronary Intervention
;
Polymers
;
Prevalence
;
Propensity Score
;
Prospective Studies
;
Stents
6.Detection and Identification of Sarcocystis cruzi (Protozoa: Apicomplexa) by Molecular and Ultrastructural Studies in Naturally Infected Korean Cattle (Bos taurus coreanae) from Daejeon, Korea
Tong Il CHOI ; Eui Ju HONG ; Si Yun RYU ; Cheolho SIM ; Joon Seok CHAE ; Hyeon Cheol KIM ; Jinho PARK ; Kyoung Seong CHOI ; Do Hyeon YU ; Jae Gyu YOO ; Bae Keun PARK
The Korean Journal of Parasitology 2018;56(2):121-127
To survey the prevalence of Sarcocystis infections, 210 heart samples were collected from Korean native cattle (Bos taurus coreanae) at an abattoir in Daejeon Metropolitan City, Republic of Korea. Sarcocysts were detected form 31 specimens (14.8%) and identified as Sarcocystis cruzi via transmission electron microscopy. The wall of S. cruzi has flattened protrusions that did not contain fibrils or microfilaments. The protrusions arose irregularly from the base, contained a fine granular substance, lacked internal microfilaments, and measured approximately 0.21–1.25 μm in length and 0.05–0.07 μm in width. Sequence analysis revealed 99.5% homology to S. cruzi. This is the first report on the prevalence of S. cruzi in native cattle from the Republic of Korea.
Abattoirs
;
Actin Cytoskeleton
;
Animals
;
Cattle
;
Heart
;
Korea
;
Microscopy, Electron, Transmission
;
Prevalence
;
Republic of Korea
;
Sarcocystis
;
Sequence Analysis
7.Epithelial-mesenchymal transition in keloid tissue.
Chae Eun YANG ; Seung Jin MOON ; Soo Jung KIM ; Ju Hee LEE ; Chae Ok YUN ; Dae Hyun LEW ; Won Jai LEE
Archives of Plastic Surgery 2018;45(6):600-601
No abstract available.
Epithelial-Mesenchymal Transition*
;
Keloid*
8.Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer.
Ye Na HA ; Hye Youn SUNG ; San Duk YANG ; Yun Ju CHAE ; Woong JU ; Jung Hyuck AHN
The Korean Journal of Physiology and Pharmacology 2018;22(1):43-51
Although cisplatin is one of the most effective antitumor drugs for ovarian cancer, the emergence of chemoresistance to cisplatin in over 80% of initially responsive patients is a major barrier to successful therapy. The precise mechanisms underlying the development of cisplatin resistance are not fully understood, but alteration of DNA methylation associated with aberrant gene silencing may play a role. To identify epigenetically regulated genes directly associated with ovarian cancer cisplatin resistance, we compared the expression and methylation profiles of cisplatin-sensitive and -resistant human ovarian cancer cell lines. We identified α-Nacetylgalactosaminidase (NAGA) as one of the key candidate genes for cisplatin drug response. Interestingly, in cisplatin-resistant cell lines, NAGA was significantly downregulated and hypermethylated at a promoter CpG site at position +251 relative to the transcriptional start site. Low NAGA expression in cisplatin-resistant cell lines was restored by treatment with a DNA demethylation agent, indicating transcriptional silencing by hyper-DNA methylation. Furthermore, overexpression of NAGA in cisplatin-resistant lines induced cytotoxicity in response to cisplatin, whereas depletion of NAGA expression increased cisplatin chemoresistance, suggesting an essential role of NAGA in sensitizing ovarian cells to cisplatin. These findings indicate that NAGA acts as a cisplatin sensitizer and its gene silencing by hypermethylation confers resistance to cisplatin in ovarian cancer. Therefore, we suggest NAGA may be a promising potential therapeutic target for improvement of sensitivity to cisplatin in ovarian cancer.
Antineoplastic Agents
;
Cell Line
;
Cisplatin*
;
DNA
;
DNA Methylation
;
Epigenomics*
;
Gene Silencing
;
Humans
;
Methylation
;
Ovarian Neoplasms*
9.Six Cases of Amelanotic Melanoma: Focused on the Difficulty of Early Differential Diagnosis.
Soo Yuhl CHAE ; Kyou Chae LEE ; Tae In PARK ; Ho Yun CHUNG ; Yong Hyun JANG ; Weon Ju LEE ; Do Won KIM ; Seok Jong LEE
Korean Journal of Dermatology 2016;54(1):62-68
Amelanotic melanoma comprises only 1.8~8.1% of malignant melanomas, and is difficult to diagnose clinically due to the lack of the diagnostic evidence of clinical pigmentation. To our knowledge, it is rarely reported, and only 10 cases have been reported in the Korean dermatological literature. It presents rather conflicting features such as a pink or red macule, papule, plaque, or nodule mimicking various benign and malignant conditions; therefore, it is difficult to diagnose. We performed a review of six patients with amelanotic melanoma focusing on differential diagnosis, particularly at the time of the initial visit. Clinical impressions included pyogenic granuloma, dermatofibrosarcoma protuberans, eccrine poroma, epidermal cyst, keloid, pilomatricoma, and squamous cell carcinoma in addition to malignant melanoma. The biopsy specimens were consistent with malignant melanoma with little or no melanin pigment on hematoxylin and eosin and Fontana-Masson stains. Four of the six patients were positive for S-100 and HMB-45, but two patients were positive for S-100 only. We report these cases to remind clinicians of the necessity of including malignant melanoma in the differential diagnosis process when patients show poor and unpredictable responses to treatment after a clinical diagnosis of other benign and malignant conditions.
Biopsy
;
Carcinoma, Squamous Cell
;
Coloring Agents
;
Dermatofibrosarcoma
;
Diagnosis
;
Diagnosis, Differential*
;
Eosine Yellowish-(YS)
;
Epidermal Cyst
;
Granuloma, Pyogenic
;
Hematoxylin
;
Humans
;
Keloid
;
Melanins
;
Melanoma
;
Melanoma, Amelanotic*
;
Pigmentation
;
Pilomatrixoma
;
Poroma
10.A Case of Methanol Poisoning Treated with Continuous Renal Replacement Therapy: The Serial Measurements of Serum Methanol Concentrations in Methanol Poisoning.
Hyun Ju YANG ; Soo Wan CHAE ; Soon Ok NOH ; Yun Jo CHUNG ; Sung Sik OH ; Mi Rim CHOI ; Jong Wha LEE ; Myung Woo CHOI ; Hyun Ju YOON ; In O SUN ; Kwang Young LEE
Journal of the Korean Society of Emergency Medicine 2016;27(5):488-491
Methanol poisoning is a medical emergency that requires rapid elimination of the toxin and its metabolites for recovery. The danger of methanol results from the accumulation of its toxic metabolite formic acid. This accumulation may result in the development of metabolic acidosis, visual impairment, and damage to the basal ganglia. Extracorporeal treatment is recommended in severe cases of methanol poisoning with coma, seizure, new vision deficits, metabolic acidosis, high serum anion gap, elevated methanol concentrations or impaired kidney function. Although the serum methanol concentration is helpful in determining the use of extracorporeal treatment, methanol assays are not standard laboratory tests in Korea. Herein, we report a case of methanol poisoning in which the patient's clinical improvement was confirmed using serum and urine methanol levels.
Acid-Base Equilibrium
;
Acidosis
;
Basal Ganglia
;
Coma
;
Emergencies
;
Extracorporeal Circulation
;
Kidney
;
Korea
;
Methanol*
;
Osmolar Concentration
;
Poisoning*
;
Renal Replacement Therapy*
;
Seizures
;
Vision Disorders

Result Analysis
Print
Save
E-mail